Lilly’s COVID-19 antibody shows promise in mid-stage study
Middle dose tested hit the primary endpoint of the Phase II trial
17th September 2020
Latest news
Sleep apnoea linked to poorer outcomes from COVID-19, study finds
People with sleep condition could be at an increased risk of adverse outcomes from COVID-19
16th September 2020
ICR study combines precision medicines to treat drug-resistant cancers
Researchers found combination treatment showed promise against a range of cancer types
16th September 2020
GenSight Biologics seeks EU approval for gene therapy
Lumevoq is designed to treat vision loss associated with Leber Hereditary Optic Neuropathy
16th September 2020
NICE unites with global health leaders to highlight evidence-based healthcare
World Evidence-based Healthcare Day takes place on 20 October
16th September 2020
A third of UK doctors have treated COVID-19 patients without full PPE, report finds
Report also highlights the impact of COVID-19 on the physical and mental health of doctors
15th September 2020
Joint letter implores government to allow pharmacists to alter prescriptions
Pharmacists, GPs and patients join arms to call for law change
15th September 2020
MSD partners with Seattle Genetics on two new oncology projects
Agreement grants MSD access to investigational ADC and a small molecule tyrosine kinase inhibitor
15th September 2020
Shionogi launches novel antibiotic Fetcroja in the UK
The drug is indicated for use as a treatment of infections caused by aerobic Gram-negative bacteria
15th September 2020
NICE backing for AZ' Tagrisso
The Institute has endorsed the drug for first-line treatment of adults with locally-advanced or EGFR mutation-positive NSCLC
14th September 2020
AZ resumes trial of COVID-19 vaccine
The move follows a green light by the UK's MHRA
14th September 2020
Gilead to buy Immunomedics for $21bn
The move adds Trodelvy, a first-in-class antibody-drug conjugate approved to treat triple-negative breast cancer, to the drugmaker's portfolio
14th September 2020
ABPI welcomes UK-Japan trade agreement
Under the deal the UK and Japan will incorporate functions of the existing EU/Japan Mutual Recognition Agreement for medicines
14th September 2020
NICE backs Portola's Ondexxya
The drug's use has, however, been restricted to reversing anticoagulation from apixaban or rivaroxaban in adults with life threatening or uncontrolled bleeding in the gastrointestinal tract
11th September 2020
AZ Fasenra shows benefit in chronic rhinosinusitis with nasal polyps
The drug reduced the size of nasal polyps and reduced nasal blockage
11th September 2020
